This webinar is sponsored by Glenmark and will be held on 17 September 2024 at 7pm. The topic is why patients with seasonal allergies cannot be treated the same way, presented by Prof Jonny Peter.
Join Medical Chronicle for a free, one-hour, CPD-accredited webinar on Why can I not treat my patients with seasonal allergies the same way. This webinar is sponsored by Glenmark.
Date: 17 September 2024
Time: 7pm
Topic: Why can I not treat my patients with seasonal allergies the same way
Speaker: Prof Jonathan Peter
Bio: Prof Jonathan Grant Peter, MB ChB, FCP (SA), MMED, PhD (UCT)
Position: Head of the Division of Allergology and Clinical Immunology, University of Cape Town (UCT)
Education:
- MBChB, University of Cape Town, First-class honors, 2000
- Fellowship of the College of Physicians of South Africa (FCP (SA)), 2009
- Master of Medicine (MMed), University of Cape Town, Distinction, 2012
- PhD, University of Cape Town, 2013.
Professional Experience:
- Oxford Nuffield Medical Fellow, John Radcliffe Hospital and the Jenner Institute, 2013-2015
- PhD Fellow and Clinical Trials Coordinator, UCT’s Lung Infection and Immunity Unit
- Internal Medicine Specialist Registrar, University of Cape Town, 2006-2009.
Academic and Research Contributions:
- Over 105 publications with an H-index of 34
- Principal investigator and co-investigator in several high-impact research projects funded by NIH and SAMRC
- Notable research in tuberculosis diagnosis and allergy.
Awards and Honours:
- Suzman and AW Meyers Medals, 2009
- Silver Medal, Medical Research Council of South Africa
- University of Cape Town Fellows award for research.
Teaching and Mentorship:
- Supervised numerous MMed, MSc, and PhD candidates
- Regular speaker at national Allergy and Immunology congresses.
Editorial Roles:
- Editorial board member, Current Allergy and Clinical Immunology Journal since 2018.
Prof Peter is a leading figure in Allergology and Clinical Immunology, recognized nationally and internationally for his clinical practice, academic scholarship, and research excellence, particularly in TB and allergy.